Targeted Toxins in Brain Tumor Therapy
2010
Targeted Toxins in Brain Tumor Therapy
publication
Evidence: moderate
Author Information
Author(s): Li Yan, Michael Hall, Walter A.
Primary Institution: State University of New York Upstate Medical University
Hypothesis
Can targeted toxins effectively treat malignant brain tumors?
Conclusion
Targeted toxins have shown promise in treating malignant brain tumors with acceptable safety profiles and evidence of tumor response.
Supporting Evidence
- Targeted toxins are more potent than traditional chemotherapy drugs.
- Clinical trials have shown evidence of tumor response with targeted toxins.
- Targeted toxins can be administered directly into tumors, improving treatment efficacy.
Takeaway
Scientists are using special toxins that can find and kill brain cancer cells without hurting normal cells, which could help patients live longer.
Methodology
This review summarizes the characteristics and clinical studies of targeted toxins used in malignant brain tumor patients.
Limitations
Obstacles include poor penetration into tumor masses and immune responses to the toxins.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website